对阻塞性睡眠呼吸暂停患者使用不同下部推进装置的副作用进行比较:系统性审查和元分析

Xi Wang1, Hui Chen2, Shaohua Ge1

  • 1Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University, Shandong, China.

概括

针对阻塞性睡眠呼吸暂停 (OSA) 的可调节下推进装置 (MAD) 与非可调节类型相比,对关节和肌的副作用较少. 然而,这两种设计都没有为所有副作用提供普遍优越的结果.

相关概念视频

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...